GE and Roche are among the companies best positioned to take advantage of future environmental, social and governance (ESG) disruption in the medical devices industry, our analysis shows.

The assessment comes from GlobalData’s Thematic Research ecosystem, which ranks companies on a scale of 1 to 5 based on their likelihood to tackle challenges like ESG and emerge as long-term winners of the medical devices sector.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

According to our analysis, 3M completes the top three of companies best positioned to benefit from investments in ESG, all of them recording scores of 5 out of 5 in GlobalData’s Medical Devices Thematic Scorecard.

The table below shows how GlobalData analysts scored the biggest companies in the medical devices industry on their ESG performance, as well as the number of new ESG jobs, deals, patents and mentions in company reports since January 2021.

The final column in the table represents the overall score given to that company when it comes to their current ESG position relative to their peers. A score of 5 indicates that a company is a dominant player in this space, while companies that score less than 3 are vulnerable to being left behind. These can be read fairly straightforwardly.

The other datapoints in the table are more nuanced, showcasing recent ESG investment across a range of areas over the past year. These metrics give an indication of whether ESG is at the top of executives’ minds now, but high numbers in these fields are just as likely to represent desperate attempts to catch-up as they are genuine strength in ESG.

For example, a high number of mentions of ESG in quarterly company filings could indicate either the company is reaping the rewards of previous investments, or it needs to invest more to catch up with the rest of the industry. Similarly, a high number of deals could indicate that a company is dominating the market, or that it is using mergers and acquisitions to fill in gaps in its offering.

This article is based on GlobalData research figures as of 21 January 2022. For more up-to-date figures, check the GlobalData website.